Rabeckan Duo Tablets 10/700 mg (Rabeprasole Sodium, Sodium Bicarbonate)

Adult dose

1) Gastric ulcer, duodenal ulcer: Normally, adults take 10/700 mg orally once a day. Depending on symptoms, 20/700 mg may be taken orally once daily. Typically, treatment lasts up to 8 weeks for gastric ulcers and 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: 10/700 mg or 20/700 mg is taken orally once a day for 4 to 8 weeks. If symptoms persist after 8 weeks of treatment, an additional 8 weeks of 10/700 mg or 20/700 mg may be administered orally twice daily, but this is only for patients with confirmed severe mucosal damage. 3) Symptom relief for gastroesophageal reflux disease: 10/700 mg is administered once a day. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms resolve, on-demand therapy with 10/700 mg once a day may be used to control any recurrence of symptoms. 4) Long-term maintenance therapy for gastroesophageal reflux disease: Depending on the patient, 10/700 mg or 20/700 mg is taken orally once daily. 2. Patients with liver disease: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, it should be administered cautiously. 3. Patients with kidney disease: The safety and efficacy for patients with kidney disease have not been established. Caution is advised due to a lack of experience using this medication in this population. 4. Elderly: Special caution should be taken as many elderly patients may have impaired liver function. 5. Children: Safety for children has not been established.

Child dose

Safety for children has not been established.

This medication should not be used in patients with allergies or hypersensitivity to certain ingredients. It is also advisable not to administer it to patients on specific antiviral medications or to pregnant or nursing women. Caution is required when used in patients with impaired liver or kidney function, the elderly, or patients with heart or lung issues. Patients with electrolyte imbalances or those who need to restrict sodium intake should also be cautious. This medication may cause allergic symptoms such as skin rashes, hives, and itching, so it should be discontinued immediately if such symptoms occur. Regular blood tests are recommended as abnormalities may arise in blood test results. Liver function tests should also be conducted regularly, and if any abnormalities in liver function are found, the medication should be discontinued. Various adverse reactions may occur in different areas, including the cardiovascular, gastrointestinal, nervous, respiratory, musculoskeletal, skin, eyes, and urinary systems, so consultation with healthcare providers is necessary if symptoms occur. Prolonged use of this medication may increase the risk of specific fractures, so it should only be taken at the minimal effective dose and duration needed. Furthermore, prolonged use may lower blood magnesium levels, requiring regular testing and supplementation if necessary. This medication lowers gastric acidity, which may increase the risk of gastrointestinal bacterial infections, so if diarrhea persists, healthcare providers should be informed. Caution is advised while driving or operating machinery as symptoms like drowsiness may occur. This medication may interact with other drugs, so it is essential to inform healthcare providers of any other medications being taken. It is recommended not to use this medication during pregnancy or nursing. The elderly should be particularly cautious due to the increased likelihood of adverse reactions stemming from decreased liver function. Safety for children has not been established, so it should not be used. In case of overdose, as no specific antidote exists, treatment should be based on symptoms, and it should be stored out of reach of children.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by coughing and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, reduced urine output.

Mild side effects

• Rash
• itching
• hives
• reduced red blood cells
• reduced white blood cells
• increased white blood cells
• increased eosinophils
• increased neutrophils
• reduced lymphocytes
• anemia

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius.

Appearance

Light yellow oval film-coated tablets

Package unit

28 tablets/bottle